biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The excuses by JD and Chrispi...

<< Previous

Bullboard Posts

Next >>

Post by zwerp2000on May 06, 2021 12:10pm

163 Views

Post# 33141181

The excuses by JD and Chrispi...

Have gone from laughable to downright sad and pathetic. It's been 10 years and this company hasn't even sniffed at a phase 1 trial. The ceo claimed to have 3 value accretive programs to announce. We got nothing. No updates on partnerships, prothena, data etc. NOTHING. The stock price is heading towards another 52 week low but JD and chrispi want you to think we are ignorant and we are wrong. Lol. Fortunately all that counts is results and this company has failed to produce for years and years. But keeping making your excuses JD, it just gives us more to make of you for and laugh

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season